EP4176881 - AQUEOUS COMPOSITION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 07.04.2023 Database last updated on 20.07.2024 | |
Former | The international publication has been made Status updated on 04.02.2022 | Most recent event Tooltip | 15.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Rohto Pharmaceutical Co., Ltd. 1-8-1 Tatsumi-nishi Ikuno-ku Osaka-shi, Osaka 544-8666 / JP | [2023/19] | Inventor(s) | 01 /
KUBO Ozora Osaka-shi, Osaka 544-8666 / JP | 02 /
HAYASHI Saeko Osaka-shi, Osaka 544-8666 / JP | 03 /
KITA Akiko Osaka-shi, Osaka 544-8666 / JP | [2023/19] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2023/19] | Application number, filing date | 21850581.6 | 30.07.2021 | [2023/19] | WO2021JP28441 | Priority number, date | JP20200129730 | 30.07.2020 Original published format: JP 2020129730 | [2023/19] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022025281 | Date: | 03.02.2022 | Language: | JA | [2022/05] | Type: | A1 Application with search report | No.: | EP4176881 | Date: | 10.05.2023 | Language: | EN | [2023/19] | Search report(s) | International search report - published on: | JP | 03.02.2022 | (Supplementary) European search report - dispatched on: | EP | 02.07.2024 | Classification | IPC: | A61K9/08, A61K31/519, A61K47/18, A61K47/22, A61P27/02 | [2024/31] | CPC: |
A61P27/02 (EP,KR);
A61K9/08 (EP,KR,US);
A61K47/22 (EP,KR,US);
A61K31/519 (EP,KR,US);
A61K47/183 (EP,KR,US);
A61K9/0048 (EP,KR,US)
|
Former IPC [2023/19] | A61K31/519, A61K9/08, A61K47/18, A61K47/22, A61P27/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/19] | Title | German: | WÄSSRIGE ZUSAMMENSETZUNG | [2023/19] | English: | AQUEOUS COMPOSITION | [2023/19] | French: | COMPOSITION AQUEUSE | [2023/19] | Entry into regional phase | 03.02.2023 | Translation filed | 03.02.2023 | National basic fee paid | 03.02.2023 | Search fee paid | 03.02.2023 | Designation fee(s) paid | 03.02.2023 | Examination fee paid | Examination procedure | 03.02.2023 | Examination requested [2023/19] | Fees paid | Renewal fee | 20.07.2023 | Renewal fee patent year 03 | 15.07.2024 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2007007832 (SANTEN PHARMACEUTICAL CO LTD [JP], et al); | [A]JP2011225626 (ROHTO PHARMA); | [X]WO2015060208 (JAPAN TOBACCO INC [JP]) | by applicant | WO2017006968 | WO2018117151 |